| CG gene | cancer-germline or cancer-testis gene |
| CIN | chromosomal instability |
| CAN | copy number alteration |
| DAC | decitabine, 5-aza-2′-deoxycytidine |
| DEG | differentially expressed gene |
| DE-CG gene | differentially expressed CG gene |
| DMC | differentially methylated CpG site |
| DMR | differentially methylated region |
| DNMT | cytosine DNA methyltransferase |
| EOC | epithelial ovarian cancer |
| FDR | false discovery rate |
| FTE | fallopian tube epithelia |
| GDHO | global DNA hypomethylation |
| GSEA | gene set enrichment analysis |
| HGSOC | high-grade serous ovarian cancer |
| IPA | Ingenuity Pathway Analysis |
| LAD | lamina-associated domain |
| NE | normal epithelia (OSE + FTE) |
| NO | bulk normal ovary |
| OSE | ovarian surface epithelia |
| PCA | principal component analysis |
| RE | repetitive DNA elements |
| RMA | robust multichip average |
| TET | Ten-eleven translocation methylcytosine dioxygenase |
| TF | transcription factor |